Bisexuality researchers have explored various aspects of bisexual (“bi”) commitment, including how bi-identified individuals negotiate nonmonogamous relationships, relationship stability in couples with 1 bi-identified and 1 straight-identified partner, and patterns of commitment across the life cycle. However, no research to date has quantitatively explored bi-identified individuals’ attitudes toward monogamy itself. As part of an online survey exploring attitudes toward monogamy in a sample of 5,988 adults, the current study examined a subsample of 293 bi-identified persons’ attitudes toward monogamy. All participants completed the Monogamy Attitudes Scale to assess attitudes toward monogamy as enhancing or sacrificing, in addition to questions regarding the sources surrounding participants’ attitudes toward monogamy. Two 2 (Male/Female) × 4 (Gay/Straight/Bi/Questioning) ANOVA results indicated a significant difference based on sexual identity for attitudes toward monogamy as enhancing, F(5) = 103.38, p < .001, and as a sacrifice, F(5) = 62.48, p < .001. Bi individuals viewed monogamy as less enhancing than gay, lesbian, and straight individuals, and similar to uncertain or questioning individuals. Bi individuals viewed monogamy as more of a sacrifice than gay, lesbian, and straight individuals, and similar to uncertain or questioning individuals. Bi-identified men viewed monogamy as more of a sacrifice than bi-identified women, F(5) = 22.09, p < .001. Findings on the sources regarding monogamy are also discussed. Overall, bi individuals expressed less supportive attitudes toward monogamy compared to other sexual identity groups despite reporting their own personal relationships as monogamous and traditional. Implications of these findings in clinical, educational, and advocacy settings are discussed.

Promescent is a lidocaine-based ejaculation delaying spray that absorbs into the skin of the penis prior to sexual activity. This article aimed to evaluate the effect of Promescent on the experience of orgasm, ejaculatory latency time and quality of sexual experience (QSE). Additionally, we assessed ease of application of Promescent and the extent to which it enhanced or interrupted the sexual experience. The analytic sample consisted of 91 men with self-reported subjective premature ejaculation who were sent a sample of Promescent and completed a 14-day internet-based prospective daily electronic report. Average ejaculatory latency time was 11.16 min during product use events, compared with 6.81 min during product non-use events. Both members of the couple had an orgasm 65.6% of the time when they used the product, compared with 44.1% when they did not use the product. QSE was significantly improved on product use days (P<0.05). Quality also significantly improved each subsequent time the product was used (P<0.01). The product was reported as easy to use and did not interrupt the sexual experience. Findings suggest that the use of this topical spray significantly improves QSE and perception of partner experience, and that these improve with longer duration of use.

No abstract